These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2277626)

  • 1. [Effect on the cell-mediated immunity of the recombinant erythropoietin after open heart surgery: preliminary report].
    Hisatomi K; Yasunaga H; Isomura T; Hirano A; Yamashita M; Kosuga K; Ohishi K
    Nihon Geka Gakkai Zasshi; 1990 Nov; 91(11):1760. PubMed ID: 2277626
    [No Abstract]   [Full Text] [Related]  

  • 2. [The changes of the cell-mediated immunity in patients with administration of recombinant erythropoietin].
    Hasatomi K; Yasunaga H; Isomura T; Fukunaga S; Hirano A; Kosuga K; Oishi K
    Nihon Geka Gakkai Zasshi; 1992 May; 93(5):518-22. PubMed ID: 1535415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of interleukin-2 production after cardiac operations in patients treated with erythropoietin.
    Hisatomi K; Isomura T; Galli SJ; Yasunaga H; Hayashida N; Ohishi K
    J Thorac Cardiovasc Surg; 1992 Aug; 104(2):278-83. PubMed ID: 1386639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of recombinant human erythropoietin on autologous blood donation for heart surgery].
    Szöcs M; Donauer E; Simon J; Gál G; Kovács G
    Orv Hetil; 1995 Aug; 136(33):1777-81. PubMed ID: 7651714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is interferon gamma suppression after cardiac surgery caused by a decreased interleukin-12 synthesis?
    Franke A; Lante W; Kurig E; Zöller LG; Weinhold C; Markewitz A
    Ann Thorac Surg; 2006 Jul; 82(1):103-9. PubMed ID: 16798198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of recombinant human erythropoietin on cardiac surgery].
    Hayashi J; Shinonaga M; Eguchi S; Shinada S
    Kokyu To Junkan; 1992 Aug; 40(8):751-7. PubMed ID: 1529171
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in lymphocyte subsets, mitogen responsiveness, and interleukin-2 production after cardiac operations.
    Hisatomi K; Isomura T; Kawara T; Yamashita M; Hirano A; Yoshida H; Eriguchi N; Kosuga K; Ohishi K
    J Thorac Cardiovasc Surg; 1989 Oct; 98(4):580-91. PubMed ID: 2796364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of recombinant erythropoietin on peripheral T lymphocytes.
    Hisatomi K; Nakao M; Isomura T; Kosuga K; Itoh K
    J Thorac Cardiovasc Surg; 1995 Apr; 109(4):809. PubMed ID: 7715233
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological alterations following open heart surgery.
    Tatke M; Khanna SK; Malhotra V; Thankamani TR; Tempe DK; Malik R; Gondal R; Nigam M
    Indian Heart J; 1991; 43(1):31-4. PubMed ID: 1894298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor lymphocytes during open heart surgery.
    Salo M; Soppi E; Lassila O; Ruuskanen O
    J Clin Lab Immunol; 1981 May; 5(3):159-63. PubMed ID: 6454000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin: a potential immunomodulator?
    Kimball PM; Kerman RH
    Transplant Proc; 1991 Feb; 23(1 Pt 1):336. PubMed ID: 1990548
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood?
    Franke A; Lante W; Kurig E; Zöller LG; Weinhold C; Markewitz A
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):64-71. PubMed ID: 16730447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human pregnancy serum inhibits interleukin-2 production.
    Nicholas NS; Panayi GS; Nouri AM
    Clin Exp Immunol; 1984 Dec; 58(3):587-95. PubMed ID: 6239719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 2 (IL 2) and cancer. In vitro response to exogenous R and non-R IL 2 by PHA-activated and non-PHA-activated PBMC from patients with cancer.
    Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
    J Exp Pathol; 1987; 3(4):539-47. PubMed ID: 3502651
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of recombinant human erythropoietin on autologous blood pre-donation in open heart surgery].
    Ono Y; Narita J; Takahashi S; Sawada M; Iwabuchi S; Tani A; Iwabuchi S; Shuto K; Fukui K; Kako N
    Kyobu Geka; 1991 Aug; 44(9):728-31. PubMed ID: 1956131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous blood donation with recombinant human erythropoietin in cardiac surgery: the Japanese experience.
    Baron JF
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):64-7; discussion 68. PubMed ID: 8723586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief report: enhanced humoral immunity in common variable immunodeficiency after long-term treatment with polyethylene glycol-conjugated interleukin-2.
    Cunningham-Rundles C; Kazbay K; Hassett J; Zhou Z; Mayer L
    N Engl J Med; 1994 Oct; 331(14):918-21. PubMed ID: 8078552
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of human recombinant erythropoietin on reduction of homologous blood transfusion in open-heart surgery. A Japanese Multicenter study.
    Kyo S; Omoto R; Hirashima K; Eguchi S; Fujita T
    Circulation; 1992 Nov; 86(5 Suppl):II413-8. PubMed ID: 1424032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of combined treatment with interleukin 1 and erythropoietin or GM-CSF and erythropoietin on the regeneration of hemopoiesis in the dog after total body irradiation--a preliminary report.
    Selig C; Nothdurft W; Kreja L; Fliedner TM
    Behring Inst Mitt; 1991 Dec; (90):86-92. PubMed ID: 1801695
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular immune functions after heart operations.
    Petri I; Kaiser G; Gaál T; Kovács G; Petri G
    Acta Chir Acad Sci Hung; 1981; 22(1-2):29-36. PubMed ID: 6213132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.